Amplia Therapeutics Ltd News

Amplia Therapeutics Ltd: First 26 Patients recruited in Phase 2A ACCENT Trial

Jul 3 07:54

Amplia Therapeutics Ltd: Annual General Meeting to be held Friday 23 August 2024

Jul 2 15:38

Amplia Therapeutics Ltd: Change of Director's Interest Notice - Dr Robert Peach

Jun 20 14:11

Amplia Therapeutics Ltd: Amplia Establishes World Class Clinical Advisory Board

Jun 3 06:33

Amplia Therapeutics Ltd: Appendix 4G - Key to Corporate Governance Disclosures

May 30 16:53

Amplia Therapeutics Ltd: 2024 Corporate Governance Statement

May 30 16:45

Amplia Therapeutics Ltd: ASCO Conference Abstract

May 24 06:37

Amplia Therapeutics Ltd: Change of Director's Interest Notice - Dr Robert Peach

May 21 15:11

Amplia Therapeutics Ltd: Change of Director's Interest Notice - Jane Bell

May 21 15:10

Amplia Therapeutics Ltd: Change of Director's Interest Notice - Chris Burns

May 21 15:09

Amplia Therapeutics Ltd: Quarterly Activities/Appendix 4C Cash Flow Report

Apr 30 06:29

Amplia Therapeutics Ltd: Trading Halt

Apr 12 07:47

Amplia Therapeutics Ltd: AACR Conference Presentation

Apr 10 06:22

Amplia Therapeutics Ltd: Update on ACCENT Trial in Pancreatic Cancer

Mar 27 05:56

Amplia Therapeutics Ltd: Quarterly Activities/Appendix 4C Cash Flow Report

Jan 30 09:33

Amplia Therapeutics Ltd: FDA Clearance Amplia's IND for Pancreatic Cancer Trial in US

Jan 18 06:42

Amplia Therapeutics Ltd: Trading Halt

Jan 17 11:26

Amplia Therapeutics Ltd: Pause in Trading

Jan 17 11:17

Amplia Therapeutics Ltd: Amplia Reports First Patient Dosing In Phase 2a Accent Trial

Jan 17 05:16

Amplia Therapeutics Ltd: Change of Director's Interest Notice - Dr Warwick Tong

Jan 2 09:48